Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "614.75",
    "chg": -16.5,
    "chgp": "-2.61%",
    "dir": -1,
    "prev_price": "631.25",
    "mcapval": "1,231.33 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE405C01035",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.44 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 732.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs73245-4003156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_priceRelatedfactors_4003156.png",
        "date": "2026-05-21 13:40:14",
        "description": "With a decisive surge to Rs 732.45 on 21 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a 66.4% rally from its low of Rs 439.95 over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader market shows signs of volatility."
      },
      {
        "title": "When is the next results date for Lincoln Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lincoln-pharmaceuticals-ltd-3999640",
        "imagepath": "",
        "date": "2026-05-19 23:17:14",
        "description": "The next results date for Lincoln Pharmaceuticals Ltd is scheduled for 28 May 2026...."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3985477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_mojoScore_3985477.png",
        "date": "2026-05-11 10:10:02",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_technicaldot_3974666.png",
        "date": "2026-05-05 08:01:25",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, signalling both opportunities and caution for investors navigating the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3970099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_mojoScore_3970099.png",
        "date": "2026-04-30 10:10:03",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 710.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs7109-3968002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_priceRelatedfactors_3968002.png",
        "date": "2026-04-29 10:10:20",
        "description": "With a decisive surge to Rs 710.9 on 29 Apr 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally comes amid a backdrop of strong technical signals and sustained gains over the past three sessions, underscoring the stock's robust upward trajectory."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3963481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_valuationdot_3963481.png",
        "date": "2026-04-27 08:00:14",
        "description": "Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This change is underpinned by improved price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, despite a modest decline in its share price on 27 Apr 2026."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3954897",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_technicaldot_3954897.png",
        "date": "2026-04-21 08:01:28",
        "description": "Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and technical strength, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3953036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LincolnPharmace_mojoScore_3953036.png",
        "date": "2026-04-19 10:10:03",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "294056",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-May-2026",
      "details": "We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March 2026.",
      "datetime": "28-May-2026",
      "details": "Outcome of Board Meeting for Audited Financial Results for the Quarter and Year Ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board approves Dividend",
      "datetime": "28-May-2026",
      "details": "Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity share of face value Rs. 10/- each for the financial year ended March 31 2026 subject to approval of the members at the ensuing Annual General Meeting of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 732.45

2026-05-21 13:40:14

With a decisive surge to Rs 732.45 on 21 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a 66.4% rally from its low of Rs 439.95 over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader market shows signs of volatility.

When is the next results date for Lincoln Pharmaceuticals Ltd?

2026-05-19 23:17:14

The next results date for Lincoln Pharmaceuticals Ltd is scheduled for 28 May 2026....

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-05-11 10:10:02

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:01:25

Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, signalling both opportunities and caution for investors navigating the pharmaceuticals and biotechnology sector.

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-04-30 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 April 2026, providing investors with the latest insights into its performance and outlook.

Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 710.9

2026-04-29 10:10:20

With a decisive surge to Rs 710.9 on 29 Apr 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally comes amid a backdrop of strong technical signals and sustained gains over the past three sessions, underscoring the stock's robust upward trajectory.

Lincoln Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-04-27 08:00:14

Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance in the Pharmaceuticals & Biotechnology sector. This change is underpinned by improved price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, despite a modest decline in its share price on 27 Apr 2026.

Lincoln Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-04-21 08:01:28

Lincoln Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and technical strength, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-04-19 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

View All News